Relay Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 02/18/2026 | 27.90 M | $236.08 M | 0.00% | 16.19% |
| COMMODORE CAPITAL LP | 02/17/2026 | 17.00 M | $143.82 M | 0.00% | 9.86% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 13.86 M | $117.25 M | -6.19% | 8.04% |
| BLACKROCK, INC. | 02/12/2026 | 13.23 M | $111.91 M | -3.86% | 7.67% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 13.00 M | $110.01 M | 14.66% | 7.54% |
| VANGUARD GROUP INC | 01/29/2026 | 9.69 M | $81.99 M | 3.15% | 5.62% |
| BELLEVUE GROUP AG | 02/17/2026 | 8.35 M | $70.60 M | 0.00% | 4.84% |
| STATE STREET CORP | 02/13/2026 | 6.43 M | $54.36 M | 26.85% | 3.73% |
| NEXTECH INVEST, LTD. | 02/17/2026 | 4.70 M | $39.77 M | 22.23% | 2.73% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.41 M | $28.85 M | 11.61% | 1.98% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 3.22 M | $27.24 M | 77.88% | 1.87% |
| 02/13/2026 | 2.98 M | $25.25 M | 100.00% | 1.73% | |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 2.48 M | $20.98 M | -0.10% | 1.44% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 2.23 M | $18.89 M | -2.20% | 1.30% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 2.10 M | $17.77 M | 78.72% | 1.22% |
| MORGAN STANLEY | 02/13/2026 | 2.02 M | $17.08 M | 14.42% | 1.17% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 1.90 M | $16.10 M | 100.00% | 1.10% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.86 M | $15.73 M | -0.49% | 1.08% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.65 M | $13.92 M | 44.63% | 0.95% |
| ALPHABET INC. | 02/13/2026 | 1.57 M | $13.27 M | 0.00% | 0.91% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.56 M | $13.20 M | 42.41% | 0.91% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 1.42 M | $12.05 M | -50.67% | 0.83% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 1.29 M | $10.91 M | 14.72% | 0.75% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.16 M | $9.84 M | -10.60% | 0.67% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 1.16 M | $9.81 M | 0.00% | 0.67% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 1.14 M | $9.66 M | 100.00% | 0.66% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.14 M | $9.63 M | -2.29% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.14 M | $9.62 M | 2.28% | 0.66% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.04 M | $8.81 M | -12.95% | 0.60% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 02/17/2026 | 1.00 M | $8.46 M | 0.00% | 0.58% |
| 02/13/2026 | 901.46 K | $7.63 M | 100.00% | 0.52% | |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 896.91 K | $7.59 M | 20.55% | 0.52% |
| INVESCO LTD. | 02/19/2026 | 865.48 K | $7.32 M | 139.62% | 0.50% |
| NORGES BANK | 02/10/2026 | 837.42 K | $7.08 M | 100.00% | 0.49% |
| WOODLINE PARTNERS LP | 02/17/2026 | 679.12 K | $5.75 M | -33.30% | 0.39% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 647.90 K | $5.48 M | -36.67% | 0.38% |
| ALLIANZ ASSET MANAGEMENT GMBH | 02/11/2026 | 560.30 K | $4.74 M | 100.00% | 0.33% |
| HIGHVISTA STRATEGIES LLC | 02/17/2026 | 545.08 K | $4.61 M | 126.68% | 0.32% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/17/2026 | 541.12 K | $4.58 M | 0.00% | 0.31% |
| 02/17/2026 | 536.95 K | $4.54 M | 100.00% | 0.31% | |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 500.10 K | $4.23 M | 100.00% | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 500.00 K | $4.23 M | 100.00% | 0.29% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 489.14 K | $4.14 M | 2.10% | 0.28% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 472.05 K | $3.99 M | 100.00% | 0.27% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2026 | 460.00 K | $3.89 M | 0.00% | 0.27% |
| BESSEMER GROUP INC | 02/05/2026 | 457.87 K | $3.87 M | -21.66% | 0.27% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 456.65 K | $3.86 M | -8.90% | 0.26% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 451.50 K | $3.82 M | 100.00% | 0.26% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 432.49 K | $3.66 M | 9.85% | 0.25% |
| JPMORGAN CHASE & CO | 02/11/2026 | 425.96 K | $3.60 M | -7.88% | 0.25% |
Relay Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 264 institutional investors and hedge funds held shares of Relay Therapeutics Inc. The most heavily invested institutionals were:
CONGRESS ASSET MANAGEMENT CO /MA: 618,938
UBS Group AG: 527,611
Bank of New York Mellon Corp: 382,920
Nuveen, LLC: 302,196
SG Americas Securities, LLC: 197,535
Raiffeisen Bank International AG: 190,000
100.67% of Relay Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 187.95 M shares in the last 24 months. This purchase volume represents approximately $1.91 B in transactions.